Latest filing: Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On Monday, July 14, 2026 For Confirmation Of Receipt Of The Differential Upfront Consideration From The Allottees Pursuant To Regulation 170(2) Of The SEBI (ICDR) Regulations, 2018
ObservedCompany dossier
Shukra Pharmaceuticals
BSE:SHUKRAPHAR · ISIN INE551C01044
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Shukra Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 50.96% and public 49.04% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On Monday, July 14, 2026 For Confirmation Of Receipt Of The Differential Upfront Consideration From The Allottees Pursuant To Regulation 170(2) Of The SEBI (ICDR) Regulations, 2018
BSE · exchange filing
Observed
Source filing Shukra Pharmaceuticals Ltd - 524632 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Shukra Pharmaceuticals Ltd - 524632 - EGM Voting Results
BSE · exchange filing
Observed
Source filing Shukra Pharmaceuticals Ltd - 524632 - Shareholder Meeting / Postal Ballot-Outcome of EGM
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 50.96%
- Public
- 49.04%
- Employee trust
- N/A
Observed BSE shareholding XBRL